Skip to main content
. 2015 Apr 14;7(4):2801–2822. doi: 10.3390/nu7042801

Table 1.

Overview of human and animal studies investigating the effects of beetroot and its derivatives on oxidative stress and inflammation.

Authors Cohort under Investigation Dosage Antioxidant Capacity of Treatment Duration Toxic inducing Protocol Inflammation Oxidative Stress Enzymatic Antioxidant Activity
[54] 48 male wistar rats Beetroot juice delivered by gavage (8 mL∙kg∙bm∙day−1; ≈1.92 mL∙day−1) 23.5 μmol Trolox equivalents∙mL−1 28 days Intraperitoneal injection of CCl4 (2 mL∙kg∙bm−1) or NDEA (150 mL∙kg∙bm−1) N/A TBARS ↓ PC ↓ DNA damage ↓ SOD ↑ GPX ↑ CAT ↑ GR ↑
[63] 80 male ICR mice Betalains from beetroot delivered orally (0, 5, 20 and 80 mg∙kg∙bm∙day−1; ≈0–1.44 mg∙day−1) N/A 30 days Exposed to cobalt-60-γ-gamma radiation (6.0 Gy, 1.5 Gy min−1) N/A MDA ↓ SOD ↑ CAT ↑ GSH ↑
[64] 24 male wistar rats Beetroot juice delivered by gavage (8 mL∙kg∙bm∙day−1) N/A 28 days Intraperitoneal injection of NDEA (150 mL∙kg∙bm−1) LDH ↓ AST ↓ ALT ↓ DNA damage ↓ GST ↑
[27] 10 osteoarthritic patients Capsules made from beetroot extract delivered orally (70–200 mg∙day−1) N/A 10 days N/A TNF-α ↓ IL-6 ↓ RANTES ↓ GRO-α ↓ AOPP ↓ N/A
[23] 48 albino wistar rats Beetroot pomace extract delivered intraperitoneally (1–3 mL∙kg∙bm∙day−1; ≈0.2–0.6 ml∙day−1) N/A 7 days Intraperitoneal injection of CCl4 (2 mL∙kg∙bm−1) N/A MDA ↓ GSH ↑ GSHPx ↑ GR ↑ CAT ↑
[65] 24 albino wistar rats Extracts of fresh beetroot delivered orally (250 and 500 mg∙kg∙bm∙day−1; ≈45–90 mg∙day−1) 90.1% radical inhibition in the DPPH• assay (500 μg∙mL−1) 28 days Intraperitoneal injection of gentamicin (8 mg∙kg∙bm−1 for 8 days) IL-6 ↓ TNF-α ↓ MPO ↓ NF-κB ↓ MDA ↓ CAT ↑ NP-SH ↑
[58] 24 female Sprague-dawley rats Beetroot juice delivered by gavage (8 mL∙kg∙bm∙day−1; ≈1.92 mL∙day−1) N/A 28 days Intraperitoneal injection of DMBA (10 mg∙kg∙bm−1 for 2 days) LDH ↓ ALT↓ N/A GST ↑ NQO1 ↑

NDEA, N-nitrosodiethylamine; GST, glutathione S-transferase; RANTES, regulated upon activation normal T cell growth; GRO-α, regulated oncogene-alpha; CCl4 carbon tetrachloride; GSH, reduced glutathione; GSHPx, glutathione peroxidase; GR, glutathione reductase; GPX, glutathione peroxidase; TNF-α, tumour necrosis factor-alpha; TBARS, thiobarbituric acid reactive species; PC, protein carbonyls; SOD, superoxide dismutase; ICR, imprinting control region; MDA, Malondialdehyde; CAT, catalase; AOPP, advanced oxidation protein products; IL-6, interleukin-6. Gy, gray unit; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; MPO, myeloperoxidase. NF-κB, nuclear factor kappa B; NP-SH, non-protein sulfhydryl; DMBA, 7,12-dimethylbenz[a]anthracene; NQO1, NAD(P)H dehydrogenase [quinone] 1.